Fertiga is the first provider worldwide on analysis of cumulus cells to improve live birth rates. The test is called the Aurora Test. By analyzing cumulus cells (the cells surround the oocyte), Fertiga can determine the oocyte with the highest quality. The corresponding embryo will be transferred first, resulting in higher live births from the first transfer.
Our aim is to improve fertility treatments to give access to more couples and to reduce the overall burden of the treatment. We strive to have as many women as possible pregnant from the first attempt. Our motto is: one try, one child.
Fertiga is a spin-off company from one of the global IVF leading centers, UZ Brussels in Belgium.
UZ Brussel has been pioneering in IVF, with the first ICSI baby worldwide born in 1992 from the Center of Reproductive Medicine of UZ Brussels.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Brussels, Brussels 1000, Be
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- fertiga.com
- HQ
- Brussels, Brussels
Fertiga Questions
Fertiga's website is fertiga.com
Fertiga's LinkedIn profile is https://be.linkedin.com/company/fertiga
Fertiga has
5 employees.
View email and phone details for 5
employees at Fertiga.
Fertiga's industry is
Hospitals and Health Care
Fertiga's top competitors are
Cirqle Biomedical,
Selectivity Life,
Sunny,
Unravel Health,
Celmatix Therapeutics,
Brussels Ivf,
Cycle Therapeutics,
May Health,
Overture Life,
Oterus Biosystems, Inc..
Fertiga's categories are Hospitals and Health Care
Fertiga's founding year is 2017
